In Segment A, individuals will get various doses and schedules of oral ABBV-744 tablet to detect Protected dosing routine. Additional individuals are going to be enrolled on the determined monotherapy dosign program. In Segment B, individuals will get oral ruxolitinib and ABBV-744 will be provided as "insert-on" therapy. In Phase https://howdoesabbv-744workincanc46790.theideasblog.com/32398072/a-simple-key-for-abbv-744-brd4-inhibition-in-cancer-cell-lines-unveiled